Gilead Sciences Stock Price on April 15, 2024
GILD Stock | USD 65.51 0.31 0.48% |
Below is the normalized historical share price chart for Gilead Sciences extending back to January 22, 1992. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Gilead Sciences stands at 65.51, as last reported on the 2nd of May, with the highest price reaching 65.89 and the lowest price hitting 64.97 during the day.
If you're considering investing in Gilead Stock, it is important to understand the factors that can impact its price. Gilead Sciences holds Efficiency (Sharpe) Ratio of -0.21, which attests that the entity had a -0.21% return per unit of risk over the last 3 months. Gilead Sciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Gilead Sciences' Standard Deviation of 1.09, risk adjusted performance of (0.16), and Market Risk Adjusted Performance of (0.48) to validate the risk estimate we provide.
At present, Gilead Sciences' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 65.2 B, whereas Common Stock Total Equity is forecasted to decline to about 892.4 K. . At present, Gilead Sciences' Price Book Value Ratio is projected to drop slightly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.80, whereas Price To Sales Ratio is forecasted to decline to 3.54. Gilead Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 22nd of January 1992 | 200 Day MA 76.2461 | 50 Day MA 71.0026 | Beta 0.203 |
Gilead |
Sharpe Ratio = -0.2119
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | GILD |
Estimated Market Risk
1.12 actual daily | 9 91% of assets are more volatile |
Expected Return
-0.24 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.21 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Gilead Sciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Gilead Sciences by adding Gilead Sciences to a well-diversified portfolio.
Price Book 3.7175 | Enterprise Value Ebitda 9.7756 | Price Sales 3.1303 | Shares Float 1.2 B | Dividend Share 3.02 |
Gilead Sciences Main Headline on 15th of April 2024
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AN... by finance.yahoo.com
Gilead Sciences, Inc. , announced a global distribution of US4 million through its ALL4LIVER Grant to support community-backed innovative projects associated with hepatitis B , hepatitis C , and hepatitis D in conjunction with the World Hepatitis Summit . An official announcement was made at a Gilead-hosted symposium titled Partnering for Global Health Equity Case Studies from Around the World, held during the World Hepatitis Summit Summit
Gilead Sciences Valuation on April 15, 2024
It is possible to determine the worth of Gilead Sciences on a given historical date. On April 15, 2024 Gilead was worth 68.34 at the beginning of the trading date compared to the closed value of 67.75. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Gilead Sciences stock. Still, in general, we apply an absolute valuation method to find Gilead Sciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Gilead Sciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Gilead Sciences' related companies.
Open | High | Low | Close | Volume | |
68.52 | 68.62 | 67.62 | 68.07 | 5,691,400 | |
04/15/2024 | 68.34 | 68.46 | 67.70 | 67.75 | 7,709,301 |
67.80 | 67.89 | 67.19 | 67.31 | 4,974,962 |
Backtest Gilead Sciences | | | Gilead Sciences History | | | Gilead Sciences Valuation | Previous | Next |
Gilead Sciences Trading Date Momentum on April 15, 2024
On April 16 2024 Gilead Sciences was traded for 67.31 at the closing time. The top price for the day was 67.89 and the lowest listed price was 67.19 . The trading volume for the day was 5 M. The trading history from April 16, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.65% . The overall trading delta against the current closing price is 0.44% . |
Gilead Sciences Fundamentals Correlations and Trends
By evaluating Gilead Sciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Gilead Sciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Gilead financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Gilead Sciences Stock history
Gilead Sciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Gilead is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Gilead Sciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Gilead Sciences stock prices may prove useful in developing a viable investing in Gilead Sciences
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 1.3 B | 1.5 B | |
Net Income Applicable To Common Shares | 5.3 B | 4.9 B |
Gilead Sciences Quarterly Net Working Capital |
|
Gilead Sciences Stock Technical Analysis
Gilead Sciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Gilead Sciences Period Price Range
Low | April 15, 2024
| High |
68.34 | 67.75 |
Gilead Sciences May 2, 2024 Market Strength
Market strength indicators help investors to evaluate how Gilead Sciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Gilead Sciences shares will generate the highest return on investment. By undertsting and applying Gilead Sciences stock market strength indicators, traders can identify Gilead Sciences entry and exit signals to maximize returns
Accumulation Distribution | 85583.83 | |||
Daily Balance Of Power | (0.78) | |||
Rate Of Daily Change | 0.99 | |||
Day Median Price | 68.08 | |||
Day Typical Price | 67.97 | |||
Price Action Indicator | (0.62) | |||
Period Momentum Indicator | (2.24) | |||
Relative Strength Index | 32.76 |
Gilead Sciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Gilead Sciences' price direction in advance. Along with the technical and fundamental analysis of Gilead Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Gilead to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.16) | |||
Jensen Alpha | (0.32) | |||
Total Risk Alpha | (0.37) | |||
Treynor Ratio | (0.49) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gilead Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for Gilead Stock analysis
When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Transaction History View history of all your transactions and understand their impact on performance | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |
Is Gilead Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gilead Sciences. If investors know Gilead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gilead Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.13) | Dividend Share 3.02 | Earnings Share 0.36 | Revenue Per Share 22 | Quarterly Revenue Growth 0.053 |
The market value of Gilead Sciences is measured differently than its book value, which is the value of Gilead that is recorded on the company's balance sheet. Investors also form their own opinion of Gilead Sciences' value that differs from its market value or its book value, called intrinsic value, which is Gilead Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gilead Sciences' market value can be influenced by many factors that don't directly affect Gilead Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gilead Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gilead Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gilead Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.